Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Al Momani, H ^a   Perry, A ^b   Stewart, C J ^c   Jones, R ^a   Krishnan, A ^a   Robertson, A G ^a   Bourke, S ^d   Doe, S ^d   Cummings, S P ^e   Anderson, A ^d   Forrest, T ^d   Griffin, S M ^d   Brodlie, M ^a   Pearson, J ^a   Ward, C ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

^c NORTHUMBRIA UNIVERSITY   (United Kingdom)

^d ROYAL VICTORIA INFIRMARY   (United Kingdom)

^e TEESSIDE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

ADOLESCENT; ADULT; AGED; BACTERIUM IDENTIFICATION; BACTEROIDES; CLASSIFICATION; COMPLICATION; CYSTIC FIBROSIS; DISCRIMINANT ANALYSIS; FAECALIBACTERIUM; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROSTOMY; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; ISOLATION AND PURIFICATION; LUNG; MALE; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PARENTERAL NUTRITION; PATHOLOGY; PSEUDOMONAS AERUGINOSA; SPUTUM; STOMACH; STOMACH JUICE; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL TYPING TECHNIQUES; BACTEROIDES; CYSTIC FIBROSIS; DISCRIMINANT ANALYSIS; FAECALIBACTERIUM; FEMALE; GASTRIC JUICE; GASTROESOPHAGEAL REFLUX; GASTROSTOMY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LUNG; MALE; MICROBIOTA; MIDDLE AGED; PARENTERAL NUTRITION; PSEUDOMONAS AERUGINOSA; RNA, RIBOSOMAL, 16S; SPUTUM; STOMACH;

EID: 84973369586     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26985     Document Type: Article

References (42)

1. Gibson, R. L., Burns, J. L. & Ramsey, B. W. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168, 918-951 (2003).
2. Andersen, D. H. Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathologic study. Am J Dis Child 56, 344-399 (1938).
3. Davis, P. B. Cystic fibrosis since 1938. Am J Respir Crit Care Med 173, 475-482 (2006).
4. Govan, J. R. & Deretic, V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60, 539-574 (1996).
5. Blondeau, K. et al. Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis. Gut 57, 1049-1055 (2008).
6. Pauwels, A. et al. Gastric emptying and different types of reflux in adult patients with cystic fibrosis. Aliment Pharmacol Ther 34, 799-807 (2011).
7. Navarro, J. et al. Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. Eur Respir J 18, 298-305 (2001).
8. Sheikh, S. I., Ryan-Wenger, N. A. & McCoy, K. S. Outcomes of surgical management of severe GERD in patients with cystic fibrosis. Pediatr Pulmonol 48, 556-562 (2013).
9. DiMango, E. et al. Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis. BMC Pulm Med 14, 21 (2014).
10. Du Moulin, G., Hedley-Whyte, J., Paterson, D. & Lisbon, A. Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonisation of the airway. The Lancet 319, 242-245 (1982).
11. Madan, J. C. et al. Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures. MBio 3, e00251-00212 (2012).
12. Segal, R., Dan, M., Pogoreliuk, I. & Leibovitz, A. Pathogenic colonization of the stomach in enterally fed elderly patients: comparing percutaneous endoscopic gastrostomy with nasogastric tube. J Am Geriatr Soc 54, 1905-1908 (2006).
13. Belafsky, P. C., Postma, G. N. & Koufman, J. A. Validity and reliability of the reflux symptom index (RSI). J Voice 16, 274-277 (2002).
14. Blauwendraat, C., Dixon, G. L. J., Hartley, J. C., Foweraker, J. & Harris, K. A. The use of a two-gene sequencing approach to accurately distinguish between the species within the Mycobacterium abscessus complex and Mycobacterium chelonae. Eur J Clin Microbiol Infect Dis 31, 1847-1853 (2012).
15. Harris, K. A. et al. Molecular fingerprinting of Mycobacterium abscessus strains in a cohort of paediatric Cystic Fibrosis patients. J Clin Microbiol, JCM. 00155-00112 (2012).
16. Turton, J. F. et al. Evaluation of a nine-locus variable-number tandem-repeat scheme for typing of Pseudomonas aeruginosa. Clin Microbiol Infect 16, 1111-1116 (2010).
17. Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K. & Schloss, P. D. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol 79, 5112-5120 (2013).
18. Schloss, P. D., Gevers, D. & Westcott, S. L. Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLos One 6, e27310 (2011).
19. Eriksson, L., Kettaneh-Wold, N., Trygg, J., Wikstrom, C. & Wold, S. Multi-and megavariate data analysis: Part I: basic principles and applications. PLS (Umetrics, Umea), pp 63-101 (2006).
20. Dickson, R. P., Martinez, F. J. & Huffnagle, G. B. The role of the microbiome in exacerbations of chronic lung diseases. The Lancet 384, 691-702 (2014).
21. Cho, I. & Blaser, M. J. The human microbiome: at the interface of health and disease. Nature Reviews Genetics 13, 260-270 (2012).
22. Bik, E. M. et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA 103, 732-737 (2006).
23. Jelsbak, L. et al. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun 75, 2214-2224 (2007).
24. Burns, J. L. et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 183, 444-452 (2001).
25. Johansson, E., Welinder-Olsson, C., Gilljam, M., Pourcel, C. & Lindblad, A. Genotyping of Pseudomonas aeruginosa reveals high diversity, stability over time and good outcome of eradication. Journal of Cystic Fibrosis 14, 353-360 (2015).
26. Mogayzel, P. J. Jr. et al. Cystic Fibrosis Foundation Pulmonary Guideline. Pharmacologic Approaches to Prevention and Eradication of Initial Pseudomonas aeruginosa Infection. Annals of the American Thoracic Society 11, 1640-1650 (2014).
27. Brodzicki, J., Trawinska-Bartnicka, M. & Korzon, M. Frequency, consequences and pharmacological treatment of gastroesophageal reflux in children with cystic fibrosis. Med Sci Monit 8, 537 (2002).
28. Huxley, E. J., Viroslav, J., Gray, W. R. & Pierce, A. K. Pharyngeal aspiration in normal adults and patients with depressed consciousness. The American journal of medicine 64, 564-568 (1978).
29. Gleeson, K., Eggli, D. F. & Maxwell, S. L. Quantitative aspiration during sleep in normal subjects. CHEST Journal 111, 1266-1272 (1997).
30. Bassis, C. M. et al. Analysis of the Upper Respiratory Tract Microbiotas as the Source of the Lung and Gastric Microbiotas in Healthy Individuals. mBio 6, e00037-00015 (2015).
31. Palm, K., Sawicki, G. & Rosen, R. The impact of reflux burden on Pseudomonas positivity in children with cystic fibrosis. Pediatr Pulmonol 47, 582-587 (2012).
32. Rosen, R. et al. 16S Community Profiling Identifies Proton Pump Inhibitor Related Differences in Gastric, Lung, and Oropharyngeal Microflora. The Journal of pediatrics 166, 917-923 (2015).
33. Walter, S. et al. Epidemiology of chronic Pseudomonas aeruginosa infections in the airways of lung transplant recipients with cystic fibrosis. Thorax 52, 318-321 (1997).
34. Nunley, D. R. et al. Allograft colonization and infections with pseudomonas in cystic fibrosis lung transplant recipients. CHEST Journal 113, 1235-1243 (1998).
35. Krishnan, A. et al. Identical Biofilm Forming Strains of Pseudomonas aeruginosa Occur in Lung Allograft BAL and Gastric Juice from CF Patients with Gastro Oesophageal Reflux. The Journal of Heart and Lung Transplantation 32, S28 (2013).
36. Griffin, S. M. et al. Aspiration and Allograft Injury Secondary to Gastroesophageal Reflux Occur in the Immediate Post-Lung Transplantation Period (Prospective Clinical Trial). Ann Surg 258, 705-712 (2013).
37. Cantu Iii, E. et al. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. The Annals of thoracic surgery 78, 1142-1151 (2004).
38. Andersson, A. F. et al. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLos one 3, e2836 (2008).
39. Zhao, J. et al. Decade-long bacterial community dynamics in cystic fibrosis airways. Proceedings of the National Academy of Sciences 109, 5809-5814 (2012).
40. Jones, R., Pearson, J. & Ward, C. Functional Dyspepsia. The New England journal of medicine 374, 895 (2016).
41. Littlewood, J. M., Wolfe, S. P. & Conway, S. P. Diagnosis and treatment of intestinal malabsorption in cystic fibrosis. Pediatr Pulmonol 41, 35-49 (2006).
42. Com, G., Cetin, N. & O'Brien, C. E. Complicated Clostridium difficile colitis in children with cystic fibrosis: Association with gastric acid suppression? Journal of Cystic Fibrosis 13, 37-42 (2014).